Rat Plasma With EDTA

Description

Rat Plasma With EDTA

Rat Plasma With EDTA is a biotechnology-grade biofluid collected from healthy rats and stabilized with ethylenediaminetetraacetic acid (EDTA) to prevent coagulation. This reagent is supplied as a 25 mL aliquot and is ideal for in vitro applications requiring native plasma components, including protein profiling, cytokine quantification, and immunoassay development. EDTA acts as a chelating agent, preserving plasma integrity by binding divalent cations and inhibiting enzymatic degradation.

Researchers use rat plasma extensively in pharmacokinetics, toxicology, and inflammation studies due to its compatibility with rodent models and its rich composition of circulating proteins, lipids, and metabolites. This product has been validated in diverse experimental contexts, including vascular reactivity, immune cell activation, and metabolic profiling. It is also suitable for use in cell culture supplementation, biomarker discovery, and formulation testing. Plasma is processed under sterile conditions, filtered through 0.22 m membranes, and prepared using Type I ultrapure water to ensure reproducibility and purity. All applications must comply with RUO guidelinesthis product is not intended for use in humans or animals.

Key benefits:

• EDTA-stabilized plasma for coagulation-free biochemical assays
• Validated in immunology, toxicology, and metabolic research
• Sterile, filtered, and ultrapure for high reproducibility
• Stable at -20C; supplied in 25 mL aliquots
• RUO-compliant: not for clinical or veterinary use

Indication for Use:
This product is for Research Use Only (RUO). It is not intended for human or animal use, diagnostic procedures, or therapeutic applications.

References:

• Johnson RC. Leptospira. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 35.
• Bateman RM et al. 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 1518 March 2016. Crit Care. 2016 Apr 20;20(Suppl 2):94.
• Asai Y. Development of an injectable formulation for the novel lipid A analog E5531 using a pH-jump method. Yakugaku Zasshi. 2004 Dec;124(12):96572.
• Bailey GB et al. Chemotaxis by Entamoeba histolytica. J Protozool. 1985 May;32(2):3416.
• Van Landuyt KL et al. Interaction of rat alveolar macrophages with dental composite dust. Part Fibre Toxicol. 2016 Nov 26;13(1):62.
• Beeton C, Chandy KG. Preparing T cell growth factor from rat splenocytes. J Vis Exp. 2007;(10):402.
• Hughes WT. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis. 1982 Jun;145(6):8428.
• Zakaria el R et al. Disparity in osmolarity-induced vascular reactivity. J Am Soc Nephrol. 2005 Oct;16(10):293140.
• Wiebe JP, Barr KJ. Suppression of spermatogenesis without inhibition of steroidogenesis by a 1,2,3-trihydroxypropane solution. Life Sci. 1984 Apr 30;34(18):174754.
• Hsu DZ et al. Therapeutic effects of sesame oil on monosodium urate crystal-induced acute inflammatory response in rats. Springerplus. 2013 Dec 7;2:659.